Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
CNS & Neurological Disorders Drug Targets|October 18, 2011
Experimental research on nitric oxide and the therapy of Alzheimer disease: a challenging bridgeRaffaella Siciliano, Eugenio Barone, Vittorio Calabrese, et al.
Neuro-Degenerative Diseases|November 26, 2015
Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's SyndromeAntonella Tramutola, Chiara Lanzillotta, Andrea Arena, et al.
Biomacromolecules|June 12, 2010
Synthesis, characterization, and anti-inflammatory activity of diclofenac-bound cotton fibersRoberta Cassano, Sonia Trombino, Teresa Ferrarelli, et al.
BMC Medicine|December 19, 2024
The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetesStanley S Schwartz, Mary E Herman, May Thet Hmu Tun, et al.
Journal of Clinical Medicine|May 28, 2020
Heme Oxygenase-1 in Central Nervous System MalignanciesGiuseppe Sferrazzo, Michelino Di Rosa, Eugenio Barone, et al.
Free Radical Biology & Medicine|May 3, 2012
Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairmentEugenio Barone, Fabio Di Domenico, Rukhsana Sultana, et al.
Neurobiology of Disease|January 29, 2020
Brain insulin resistance triggers early onset Alzheimer disease in Down syndromeAntonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Journal of Neurochemistry|October 19, 2011
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer diseaseEugenio Barone, Cesare Mancuso, Fabio Di Domenico, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 1, 2020
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down SyndromeIlaria Zuliani, Chiara Lanzillotta, Antonella Tramutola, et al.
Pageof 11